Cardiology Review - Issue 3/2017
152
Cardiovascular risk stratification and new serum lipid target levels
E. Tůmová, M. Vráblík
157
Management of dyslipidaemias in specific patient groups
M. Vaclová, M. Vráblík, R. Češka
161
Statin intolerance – finding practical solutions
M. Šnejdrlová
165
168
Is heart failure with preserved ejection fraction a serious illness?
J. Murín, M. Macháčová, R. Compagnon, J. Bulas, M. Wawruch
172
177
Infective Endocarditis
M. Tesák, J. Pařenica, E. Míšková
183
Catheter ablation in atrial fibrillation and direct anticoagulants
J. Špinar, R. Lábrová
187
Thirty years of renin-angiotensin-aldosterone system inhibition in chronic heart failure
J. Vítovec, J. Špinar, L. Špinarová
195
SGLT2 inhibitors (gliflozins) antidiabetics, antihypertensives or drugs for heart failure?
J. Špinar, J. Vítovec, L. Špinarová
201
Zoletorv – pharmacological profile
B. Nussbaumerová
205
Educational activities of nurses in patients after myocardial infarction – a review
J. Doležel, D. Jarošová
Cardiology Review
2017 Issue 3
Most read in this issue
- Cardiovascular risk stratification and new serum lipid target levels
- SGLT2 inhibitors (gliflozins) antidiabetics, antihypertensives or drugs for heart failure?
- Statin intolerance – finding practical solutions
- Infective Endocarditis